These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3039832)

  • 21. Nuclear DNA measurements in squamous cell carcinoma of the lung: a guide for prognostic evaluation.
    Blöndal T; Bengtsson A
    Anticancer Res; 1981; 1(2):79-86. PubMed ID: 7051956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of epidermal growth factor receptors in four histologic cell types of lung cancer.
    Kaseda S; Ueda M; Ozawa S; Ishihara T; Abe O; Shimizu N
    J Surg Oncol; 1989 Sep; 42(1):16-20. PubMed ID: 2549305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of vimentin in surgically resected adenocarcinomas and large cell carcinomas of lung.
    Upton MP; Hirohashi S; Tome Y; Miyazawa N; Suemasu K; Shimosato Y
    Am J Surg Pathol; 1986 Aug; 10(8):560-7. PubMed ID: 2426981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence of human papillomavirus DNA in primary lung neoplasms.
    Yousem SA; Ohori NP; Sonmez-Alpan E
    Cancer; 1992 Feb; 69(3):693-7. PubMed ID: 1309679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small-cell-type poorly differentiated squamous cell carcinoma of the lung. Cytologic, immunohistochemical and nuclear DNA content analysis.
    Abe S; Ogura S; Nakajima I; Makimura S; Kawakami Y; Inoue K
    Anal Quant Cytol Histol; 1990 Apr; 12(2):73-7. PubMed ID: 1693507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of mutant forms of p53 oncogene in primary lung cancer.
    Iggo R; Gatter K; Bartek J; Lane D; Harris AL
    Lancet; 1990 Mar; 335(8691):675-9. PubMed ID: 1969059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immune response at the tumor site in lung carcinoma.
    Ioachim HL; Dorsett BH; Paluch E
    Cancer; 1976 Dec; 38(6):2296-309. PubMed ID: 187316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
    Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
    Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a glycoprotein isolated from a continuous tumor-cell line of human lung carcinoma.
    Mohapatra N; Lynn WS; Bhattacharyya SN
    Biochim Biophys Acta; 1983 Nov; 760(3):398-402. PubMed ID: 6313068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transthoracic aspiration cytology of pulmonary lesions.
    Zaman MB; Hajdu SI; Melamed MR; Watson RC
    Semin Diagn Pathol; 1986 Aug; 3(3):176-87. PubMed ID: 3039634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
    Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
    Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycosaminoglycans in lung carcinoma.
    Kawai T; Suzuki M; Kageyama K
    Hum Pathol; 1988 Nov; 19(11):1288-92. PubMed ID: 2846421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical localisation of keratin in human lung tumours.
    Gusterson B; Mitchell D; Warburton M; Sloane J
    Virchows Arch A Pathol Anat Histol; 1982; 394(3):269-77. PubMed ID: 6176066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Histogenetic classification of bronchopulmonary carcinomas and WHO histological typing].
    Eskenasy A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(1):1-10. PubMed ID: 6264563
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nuclear DNA content and focal relapse of patients with small-cell carcinoma of the lung].
    Abe S; Tsuneta Y; Nagai T; Makimura S; Itabashi K; Kawakami Y
    Gan No Rinsho; 1986 Mar; 32(3):241-5. PubMed ID: 3012137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical demonstration of lacto-N-fucopentose III in lung carcinomas with monoclonal antibody 624A12.
    Lee I; Warren WH; Gould VE; Radosevich JA; Ma YX; Rosen ST
    Pathol Res Pract; 1987 Feb; 182(1):40-7. PubMed ID: 3035522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytologic diagnosis of lung cancer.
    Petrova AS
    Cancer Treat Rep; 1976 Oct; 60(10):1467-8. PubMed ID: 191186
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipase member H is a novel secreted protein selectively upregulated in human lung adenocarcinomas and bronchioloalveolar carcinomas.
    Seki Y; Yoshida Y; Ishimine H; Shinozaki-Ushiku A; Ito Y; Sumitomo K; Nakajima J; Fukayama M; Michiue T; Asashima M; Kurisaki A
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1141-7. PubMed ID: 24380866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intracellular and extracellular acid mucopolysaccharides in human bronchus carcinoma and lung metastases - prognostic parameters?].
    Kolb E; Müller E; Largiadèr F
    Helv Chir Acta; 1980 Jun; 47(1-2):55-9. PubMed ID: 6254917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lung cancer - an inventory].
    Wassner UJ; Timm J
    Chirurg; 1981 Apr; 52(4):219-24. PubMed ID: 6262028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.